Prospera Financial Services Inc increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 204.2% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 2,917 shares of the company's stock after acquiring an additional 1,958 shares during the period. Prospera Financial Services Inc's holdings in HCA Healthcare were worth $1,186,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also made changes to their positions in the company. CreativeOne Wealth LLC bought a new position in shares of HCA Healthcare during the first quarter worth about $231,000. Bessemer Group Inc. increased its holdings in shares of HCA Healthcare by 51.2% during the first quarter. Bessemer Group Inc. now owns 7,629 shares of the company's stock valued at $2,543,000 after purchasing an additional 2,584 shares during the period. Swedbank AB acquired a new stake in shares of HCA Healthcare in the 1st quarter worth approximately $95,882,000. EP Wealth Advisors LLC boosted its stake in HCA Healthcare by 1.6% during the 2nd quarter. EP Wealth Advisors LLC now owns 225,146 shares of the company's stock valued at $72,335,000 after purchasing an additional 3,516 shares in the last quarter. Finally, AustralianSuper Pty Ltd grew its holdings in HCA Healthcare by 118.5% during the third quarter. AustralianSuper Pty Ltd now owns 35,493 shares of the company's stock worth $14,425,000 after acquiring an additional 19,247 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.
Several research analysts have issued reports on the company. TD Cowen dropped their price target on HCA Healthcare from $450.00 to $440.00 and set a "buy" rating on the stock in a report on Monday, October 28th. Wells Fargo & Company upped their price target on shares of HCA Healthcare from $395.00 to $400.00 and gave the company an "equal weight" rating in a research report on Wednesday, November 6th. UBS Group boosted their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a "buy" rating in a research note on Wednesday, August 14th. Royal Bank of Canada upped their price target on HCA Healthcare from $378.00 to $405.00 and gave the company an "outperform" rating in a research report on Friday, August 23rd. Finally, KeyCorp dropped their target price on HCA Healthcare from $475.00 to $420.00 and set an "overweight" rating on the stock in a report on Monday, October 28th. Five investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $385.00.
Get Our Latest Stock Report on HCA Healthcare
Shares of HCA opened at $332.22 on Friday. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The company's fifty day moving average price is $380.80 and its 200 day moving average price is $357.94. The company has a market capitalization of $84.15 billion, a PE ratio of 14.92, a price-to-earnings-growth ratio of 1.29 and a beta of 1.68. HCA Healthcare, Inc. has a one year low of $245.84 and a one year high of $417.14.
The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.79%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare's dividend payout ratio (DPR) is presently 11.85%.
In other news, insider Erol R. Akdamar sold 2,900 shares of the company's stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares in the company, valued at approximately $2,415,579. This represents a 29.76 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,155 shares of company stock valued at $5,608,990 over the last three months. 1.60% of the stock is owned by corporate insiders.
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.